-
-
-
-
-
-
-
Qiagen tops Q2 outlook with flat sales, reaffirms 2026 guidance
-
-
-
-
-
-
-
QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma
-
-
-
-
-
-
-
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
-
-
-
-
-
-
-
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
-
-
-
-
-
-
-
Qiagen (QGEN) Reports In-Line Q4 EPS, provides outlook
-
-
-
-
-
-
-
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
-
-
-
-
-
-
-
QIAGEN launches automated sexual assault DNA processing kit
-
1,224,181 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

